Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388643 · ClinicalTrials.gov registry record · NA
Early Detection of Gestational Diabetes Mellitus in Pregnancy
A NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05388643: Recruiting NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy, sponsored by University of Massachusetts, Worcester.
NCT05388643 is a NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 80 participants, below the 313-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05388643, a NA study of Pregnancy, High Risk and Gestational Diabetes Mellitus in Pregnancy, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).
Primary Outcome
Confirmed diagnosis of GDM based on 3 hour 100 gram glucose tolerance test
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Enhanced First Trimester GDM Screening
- DIAGNOSTIC_TEST Routine Gestational Diabetes Screening
Study Locations (1)
Massachusetts
- University of Massachusetts Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-08-18 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT05388643 shows while recruiting
NCT05388643 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 313-participant average among 20 other Pregnancy, High Risk trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Pregnancy, High Risk appearing as the primary indexed condition, and to 2 interventions - of which Enhanced First Trimester GDM Screening is the first listed.
NCT05388643 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05388643 about?
NCT05388643 is a clinical study titled "Early Detection of Gestational Diabetes Mellitus in Pregnancy". The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).
What is the current status of trial NCT05388643?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-08-18. Estimated completion is 2026-12-01.
What conditions does trial NCT05388643 study?
This clinical trial studies the following conditions: Pregnancy, High Risk, Gestational Diabetes Mellitus in Pregnancy.
What interventions are being tested in trial NCT05388643?
The interventions under investigation include: Enhanced First Trimester GDM Screening (DIAGNOSTIC_TEST), Routine Gestational Diabetes Screening (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05388643?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05388643 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy, High Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05388643's enrollment target sits among peer trials
80 12th of 20 higher than 9 of 20 other Pregnancy, High Risk trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy, High Risk trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Continuous Glucose Monitor Use in Pregnancy
RECRUITING · NA
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
RECRUITING · NA
-
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
RECRUITING · NA
-
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
RECRUITING · NA
-
Daily Meditation Program in Women Admitted to the Antepartum Unit
COMPLETED · NA
-
A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI